Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA

Parallel session 1 – Open oral presentations Topic: Pancreas transplantation: Results and surgical aspects

1.3 - Laparoscopic robot-assisted pancreas transplantation

Presenter: U., Boggi, Pisa, Italy
Authors: U. Boggi, F. Vistoli, S. Signori, S. D'Imporzano, G. Amorese, G. Consani, F. Guarracino, P. Marchetti, D. Focosi, F. Mosca


Laparoscopic robot-assisted pancreas transplantation

U. Boggi1, F. Vistoli1, S. Signori1, S. D'Imporzano1, G. Amorese2, G. Consani2, F. Guarracino3, P. Marchetti4, D. Focosi5, F. Mosca6
1 Division of General and Transplant Surgery - Pisa University Hospital , Pisa, Italy; 2 Division of General and Vascular Anesthesia and Intensive Care - Pisa University Hospital, Pisa, Italy; 3 Division of Cardiothoracic Anesthesia and Intensive Care - Pisa University Hospital, Pittsburgh, USA; 4 Section of Transplant Endocrinology and Metabolism - Pisa University Hospital, Pisa, Italy; 5 Division of Immunohematology - Pisa University Hospital, Pisa, Italy; 6 Division of General Surgery I - Pisa University Hospital, Pisa, Italy

Background: Surgical complications are a major disincentive to pancreas transplantation, despite theundisputed benefits of restored insulin independence. The da Vinci surgicalsystem, a computer assisted electromechanical device, provides the uniqueopportunity to test whether laparoscopy can reduce the morbidity of pancreastransplantation.

Methods: Pancreas transplantation was performed by robot assisted laparoscopyin three patients. The first patient received a pancreas after kidneytransplant, the second a simultaneous pancreas kidney transplantation, and thethird a pancreas transplant alone. Operations were carried out through an 11 mmoptic port, two 8 mm operative ports, and a 7 cm midline incision. The latterwas used to introduce the grafts, handle vascular crossclamping, and createexocrine drainage into the jejunum.

Results: The two solitary pancreas transplants lasted 3 and 5hrs, respectively, the simultaenous pancreas kidney transplantation lasted 8 hrs.Mean warm ischemia time of the pancreas graft was 34 minutes. All pancreata functioned immediately,making their recipients insulin-independent. The kidney graft, revascularizedafter 35 minutes of warm ischemia, also functioned immediately and fully. Nopatient had complications during or after surgery; mean hospital stay was 23 days. After a mean follow-up period of 3.7 months, allrecipients are alive with optimal graft function.

Conclusion: We have shown the feasibility of laparoscopicrobot-assisted solitary pancreas and simultaneous pancreas and kidneytransplantation. If the safety and feasibility of this procedure can be confirmedin larger series, laparoscopic robot assisted pancreas transplantation couldbecome a new option for diabetics needing beta-cell replacement.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada